Company intelligence / Profile preview

Shanghai Pharma Group Changzhou Kony Pharmaceutical

Changzhou, Jiangsu, Chinaen.kanglipharm.com ↗

Ownership: Private
Employees: ~240
Development stage: Other

Overview

The company manufactures bulk pharmaceutical ingredients and intermediates, with a focus on nucleoside antivirals and sartans. It operates at commercial scale with GMP-compliant facilities. No clinical trial results are reported as it does not develop finished drugs but supplies APIs/intermediates.

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Collaborations with colleges, universities, research institutes for technical research and new product development

Beyond the preview

Go deeper on Shanghai Pharma Group Changzhou Kony Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Pharma Group Changzhou Kony Pharmaceutical.

Explore the full profile